Published in
Elsevier, Molecular and Cellular Endocrinology, (501), p. 110642, 2020
DOI: 10.1016/j.mce.2019.110642
Links
Tools
Empagliflozin attenuates ischemia and reperfusion injury through LKB1/AMPK signaling pathway
Journal article published in 2020 by
Qingguo Lu,
Jia Liu,
Xuan Li,
Xiaodong Sun,
Jingwen Zhang,
Di Ren,
Nanwei Tong 
,
Ji Li
,
Ji Li
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 